• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马拉喀什市城市废水中产超广谱β-内酰胺酶(ESBL)大肠杆菌的耐药性及分子检测

Antimicrobial resistance and molecular detection of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in municipal wastewater in Marrakech.

作者信息

El Garraoui Oumaima, Loqman Amal, Amouat Fatima-Ezahra, Hasnaoui Said, Soraa Nabila, Loqman Souad

机构信息

Laboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.

Laboratoire de Microbiologie, CHU Mohammed VI, Av Ibn Sina Amerchich, Marrakech, Morocco.

出版信息

PLoS One. 2025 Jun 16;20(6):e0325816. doi: 10.1371/journal.pone.0325816. eCollection 2025.

DOI:10.1371/journal.pone.0325816
PMID:40522962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12169590/
Abstract

Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) poses a major threat to public health. However, its environmental dissemination, especially through wastewater, remains insufficiently addressed. This paper examines the presence of ESBL-EC in composite influent and effluent samples from Marrakech's wastewater treatment plant. Samples were screened on selective agar and isolated strains were identified by MALDI Biotyper® Sirius System. The sensitivity of bacteria to antibiotics was determined by disk diffusion method and phenotypic tests were conducted to detect ESBL production. Molecular identification was characterized by PCR and DNA sequencing. From a total of 72 wastewater samples, 364 resistant Enterobacteriaceae isolates were recovered, of which 134 were confirmed as ESBL-EC, with 78.35% exhibiting multidrug resistance (MDR) phenotypes. The blaCTX-M gene was the most prevalent among isolates obtained from influent samples, followed by blaTEM at 81.25% and blaSHV at 16.67%. Although biological treatment reduced the number of ESBL-EC isolates harboring resistance genes, a significant proportion remained detectable in the final effluent, even after UV disinfection, highlighting the limited efficacy of standard treatment processes in eliminating them. These findings underscore the urgent need to enhance wastewater treatment strategies. Implementing advanced technologies, such as membrane filtration or ozonation, combined with routine monitoring, is critical to reduce the environmental release of resistant bacteria and mitigate their public health risks.

摘要

产超广谱β-内酰胺酶大肠杆菌(ESBL-EC)对公众健康构成重大威胁。然而,其在环境中的传播,尤其是通过废水的传播,仍未得到充分解决。本文研究了马拉喀什污水处理厂进水和出水混合样本中ESBL-EC的存在情况。样本在选择性琼脂上进行筛选,分离出的菌株通过MALDI Biotyper® Sirius系统进行鉴定。采用纸片扩散法测定细菌对抗生素的敏感性,并进行表型试验以检测ESBL的产生。通过PCR和DNA测序进行分子鉴定。在总共72个废水样本中,共回收了364株耐药肠杆菌科分离株,其中134株被确认为ESBL-EC,78.35%表现出多重耐药(MDR)表型。blaCTX-M基因在进水样本分离株中最为普遍,其次是blaTEM,占81.25%,blaSHV占16.67%。尽管生物处理减少了携带耐药基因的ESBL-EC分离株数量,但即使经过紫外线消毒,仍有相当比例的菌株在最终出水中可检测到,这突出了标准处理工艺在消除它们方面的有限效果。这些发现强调了加强废水处理策略的迫切需求。实施先进技术,如膜过滤或臭氧处理,并结合常规监测,对于减少耐药菌的环境排放和降低其对公众健康的风险至关重要。

相似文献

1
Antimicrobial resistance and molecular detection of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in municipal wastewater in Marrakech.马拉喀什市城市废水中产超广谱β-内酰胺酶(ESBL)大肠杆菌的耐药性及分子检测
PLoS One. 2025 Jun 16;20(6):e0325816. doi: 10.1371/journal.pone.0325816. eCollection 2025.
2
Wastewater based genomic surveillance key to population level monitoring of AmpC/ESBL producing Escherichia coli.基于废水的基因组监测是对产AmpC/ESBL大肠杆菌进行人群水平监测的关键。
Sci Rep. 2025 Mar 3;15(1):7400. doi: 10.1038/s41598-025-91516-9.
3
Extended-spectrum β-lactamase-producing bacteria and their resistance determinants in different wastewaters and rivers in Nepal.尼泊尔不同废水中和河流中的产超广谱β-内酰胺酶细菌及其耐药决定因子。
J Hazard Mater. 2024 Jul 15;473:134660. doi: 10.1016/j.jhazmat.2024.134660. Epub 2024 May 20.
4
A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location.时间和地点相关的临床、娱乐用水和废水样本中产Extended-spectrum β-lactamase 的大肠杆菌比较。
PLoS One. 2017 Oct 17;12(10):e0186576. doi: 10.1371/journal.pone.0186576. eCollection 2017.
5
Resolved genomes of wastewater ESBL-producing and metagenomic analysis of source wastewater samples.解析废水中产 ESBL 菌的基因组和原废水样本的宏基因组分析。
Microbiol Spectr. 2024 Oct 3;12(10):e0071724. doi: 10.1128/spectrum.00717-24. Epub 2024 Aug 21.
6
Prevalence and molecular characterization of ESBL-producing Escherichia coli isolated from broiler chicken and their respective farms environment in Malaysia.马来西亚肉鸡及其养殖场环境中产 ESBL 大肠杆菌的流行情况及分子特征。
BMC Microbiol. 2024 Nov 26;24(1):499. doi: 10.1186/s12866-024-03653-2.
7
Extended-spectrum beta-lactamase-producing and : insights from a tertiary hospital in Southern Thailand.产超广谱β-内酰胺酶和:来自泰国南部一家三级医院的见解。
Microbiol Spectr. 2024 Jul 2;12(7):e0021324. doi: 10.1128/spectrum.00213-24. Epub 2024 May 29.
8
Solid waste dumpsite leachate and contiguous surface water contain multidrug-resistant ESBL-producing Escherichia coli carrying Extended Spectrum β-Lactamase (ESBL) genes.固体废物堆放场渗滤液和相邻地表水含有携带扩展谱β-内酰胺酶(ESBL)基因的多药耐药 ESBL 产大肠埃希菌。
BMC Microbiol. 2024 Aug 20;24(1):308. doi: 10.1186/s12866-024-03444-9.
9
Tracking antimicrobial resistance transmission in urban and rural communities in Bangladesh: a One Health study of genomic diversity of ESBL-producing and carbapenem-resistant .追踪孟加拉国城乡社区中的抗生素耐药性传播:一项针对产 ESBL 和碳青霉烯类耐药菌的基因组多样性的 One Health 研究。
Microbiol Spectr. 2024 Jun 4;12(6):e0395623. doi: 10.1128/spectrum.03956-23. Epub 2024 May 3.
10
Occurrence of the Colistin Resistance Gene and Additional Antibiotic Resistance Genes in ESBL/AmpC-Producing Escherichia coli from Poultry in Lebanon: A Nationwide Survey.在黎巴嫩家禽中分离的产 ESBL/AmpC 酶大肠杆菌中黏菌素耐药基因和其他抗生素耐药基因的流行情况:一项全国性调查。
Microbiol Spectr. 2021 Oct 31;9(2):e0002521. doi: 10.1128/Spectrum.00025-21. Epub 2021 Sep 8.

本文引用的文献

1
The presence of antibiotic-resistant bacteria at four Norwegian wastewater treatment plants: seasonal and wastewater-source effects.挪威四个污水处理厂中抗生素耐药菌的存在:季节和污水源的影响。
Front Antibiot. 2024 Feb 7;3:1351999. doi: 10.3389/frabi.2024.1351999. eCollection 2024.
2
Escherichia coli: An arduous voyage from commensal to Antibiotic-resistance.大肠杆菌:从共生菌到抗生素耐药菌的艰难历程。
Microb Pathog. 2025 Jan;198:107173. doi: 10.1016/j.micpath.2024.107173. Epub 2024 Nov 27.
3
Resistome analysis of wastewater treatment plants in Agadir city, Morocco, using a metagenomics approach.
使用宏基因组学方法分析摩洛哥阿加迪尔市污水处理厂的耐药组。
Sci Rep. 2024 Nov 1;14(1):26328. doi: 10.1038/s41598-024-76773-4.
4
Public health implications of antibiotic resistance in sewage water: an epidemiological perspective.污水中抗生素耐药性对公共卫生的影响:流行病学视角
Bioresour Bioprocess. 2024 Sep 28;11(1):91. doi: 10.1186/s40643-024-00807-y.
5
Antibiotic Residues and Resistance in Three Wastewater Treatment Plants in Romania.罗马尼亚三座污水处理厂中的抗生素残留与耐药性
Antibiotics (Basel). 2024 Aug 19;13(8):780. doi: 10.3390/antibiotics13080780.
6
The Role of Wastewater Treatment Plants in Dissemination of Antibiotic Resistance: Source, Measurement, Removal and Risk Assessment.污水处理厂在抗生素耐药性传播中的作用:来源、测量、去除及风险评估
Antibiotics (Basel). 2024 Jul 18;13(7):668. doi: 10.3390/antibiotics13070668.
7
A review of the mechanisms that confer antibiotic resistance in pathotypes of .一种对赋予 病原菌抗生素耐药性的机制的综述。
Front Cell Infect Microbiol. 2024 Apr 4;14:1387497. doi: 10.3389/fcimb.2024.1387497. eCollection 2024.
8
Monitoring ESBL- in Swiss wastewater between November 2021 and November 2022: insights into population carriage.监测瑞士污水中的 ESBL- :2021 年 11 月至 2022 年 11 月期间的人群携带情况。
mSphere. 2024 May 29;9(5):e0076023. doi: 10.1128/msphere.00760-23. Epub 2024 Apr 12.
9
Inter-plasmid transfer of antibiotic resistance genes accelerates antibiotic resistance in bacterial pathogens.质粒间抗生素耐药基因的转移加速了细菌病原体的抗生素耐药性。
ISME J. 2024 Jan 8;18(1). doi: 10.1093/ismejo/wrad032.
10
Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities.超广谱β-内酰胺酶(ESBL):挑战与机遇
Biomedicines. 2023 Oct 30;11(11):2937. doi: 10.3390/biomedicines11112937.